Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients With Major Depressive Disorder. Precis. Med. Com. 2022, 2 (1), 27-42. https://doi.org/10.55627/pmc.002.01.0044.